Literature DB >> 21920362

Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated.

Daniel Reinecke1, Heike Burhenne, Peter Sandner, Volkhard Kaever, Roland Seifert.   

Abstract

Phosphodiesterases (PDEs) capable of degrading cAMP and cGMP are indispensable for the regulation of cyclic nucleotide-mediated signals. The existence of other cyclic nucleotides such as cCMP and cUMP has been discussed controversially in the literature. Despite publications on PDEs hydrolyzing cCMP or cUMP, the molecular identity of such enzymes remained elusive. Recently, we have provided evidence for a role of cCMP as second messenger in vascular relaxation and inhibition of platelet aggregation. Using an HPLC-MS based assay, here, we show that human PDEs belonging to various families hydrolyze not only cAMP and cGMP but also other cyclic nucleotides.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920362     DOI: 10.1016/j.febslet.2011.09.004

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.

Authors:  Dan Li; David J Paterson
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

Review 2.  The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.

Authors:  K Adam Morrow; Dara W Frank; Ron Balczon; Troy Stevens
Journal:  Handb Exp Pharmacol       Date:  2017

3.  Is cIMP a second messenger with functions opposite to those of cGMP?

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-15       Impact factor: 3.000

4.  Tissues cIMPly do not lie.

Authors:  Yuansheng Gao; Paul M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-23       Impact factor: 3.000

5.  cUMP hydrolysis by PDE3A.

Authors:  Stefan Berrisch; Jessica Ostermeyer; Volkhard Kaever; Solveig Kälble; Denise Hilfiker-Kleiner; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

6.  cUMP hydrolysis by PDE3B.

Authors:  Jessica Ostermeyer; Franziska Golly; Volkhard Kaever; Stefan Dove; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

7.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

8.  Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.

Authors:  Dan Li; Chieh-Ju Lu; Guoliang Hao; Hannah Wright; Lavinia Woodward; Kun Liu; Elisa Vergari; Nicoletta C Surdo; Neil Herring; Manuela Zaccolo; David J Paterson
Journal:  Hypertension       Date:  2015-04-27       Impact factor: 10.190

9.  Hydrolysis of the non-canonical cyclic nucleotide cUMP by PDE9A: kinetics and binding mode.

Authors:  Jessica Scharrenbroich; Volkhard Kaever; Stefan Dove; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-15       Impact factor: 3.000

10.  cCMP is a substrate for MRP5.

Authors:  Svenja Laue; Moritz Winterhoff; Volkhard Kaever; Jeroen J van den Heuvel; Frans G Russel; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.